Social media

Join us at #IRT2025 as we explore the evolving landscape of IMP management. ICON’s Mia Carter will join a panel discussing the tension between sponsor mandates and site autonomy, and how collaboration can drive regulator...

Are biomarkers the key to reversing high failure rates in neurodegenerative trials? Biomarkers are no longer just exploratory tools, they’re central to improving trial precision and outcomes. Join Dr. Peter Schueler, MD...

Latest issue out now. If you, like our thousands of subscribers, would like a convenient way to keep on top of the latest regulatory authority updates, sign up to our free newsletter today: https://ow.ly/UlO350X4NqJ C...

Latest issue out now. If you, like our thousands of subscribers, would like a convenient way to keep on top of the latest regulatory authority updates, sign up to our free newsletter today: https://ow.ly/wzQ950X4eSt C...

ICON offers proven expertise in complex oncology trials, supporting sponsors from trial design through execution. Discover our success stories.​ https://ow.ly/ECj550WY1i4

ICON offers proven expertise in complex oncology trials, supporting sponsors from trial design through execution. Discover our success stories.​ https://ow.ly/Rnix50WY1i2

ICON will be participating in ACOP 2025 in Aurora, Colorado, where we will introduce Yi Zhang, our new Scientific Director of PK in the Pharmacometrics Department. Yi brings extensive expertise in PK/PD modeling, disea...

ICON will be participating in ACOP 2025 in Aurora, Colorado, where we will introduce Yi Z., our new Scientific Director of PK in the Pharmacometrics Department. Yi brings extensive expertise in PK/PD modeling, disease ...

Visit booth 409 at #RAPSConvergence2025 to meet ICON’s Regulatory Affairs team. Stop by to discuss how we can support your regulatory strategy, CMC, project management, medical device and post-market requirements across ...

ICON is proud to be a sponsor at the upcoming #OCTNordics conference, taking place on 21–22 October in Copenhagen, Denmark. Join us at booth #41 to connect with our experts and explore how ICON is driving innovation and...

ICON is proud to be a sponsor at the upcoming #OCTNordics conference, taking place on 21–22 October in Copenhagen, Denmark. Join us at booth \#41 to connect with our experts and explore how ICON is driving innovation an...

On 28 October at 2:15 PM, ICON’s Suzanne Jansen, Head of QC Accelerated Pharmaceutical Solutions will present a session on Clinical innovation: Enabling dosing flexibility in early phase trials, an integrated CMC and man...